218 related articles for article (PubMed ID: 37196065)
21. Thyrocyte interleukin-18 expression is up-regulated by interferon-γ and may contribute to thyroid destruction in Hashimoto's thyroiditis.
Liu Z; Wang H; Xiao W; Wang C; Liu G; Hong T
Int J Exp Pathol; 2010 Oct; 91(5):420-5. PubMed ID: 20586818
[TBL] [Abstract][Full Text] [Related]
22. Analysis of T cell receptor Vbeta diversity in peripheral CD4 and CD8 T lymphocytes in patients with autoimmune thyroid diseases.
Okajima M; Wada T; Nishida M; Yokoyama T; Nakayama Y; Hashida Y; Shibata F; Tone Y; Ishizaki A; Shimizu M; Saito T; Ohta K; Toma T; Yachie A
Clin Exp Immunol; 2009 Feb; 155(2):166-72. PubMed ID: 19040601
[TBL] [Abstract][Full Text] [Related]
23. Dysfunction of CD24+CD38+ B cells in patients with Hashimoto's thyroiditis is associated with a lack of interleukin 10.
Yu S; Qi Y; Wang H; Jiang J; Sun L; Zhou Q
Int J Biochem Cell Biol; 2017 Sep; 90():114-120. PubMed ID: 28827034
[TBL] [Abstract][Full Text] [Related]
24. Clonally expanded CD38
Wang R; Singaraju A; Marks KE; Shakib L; Dunlap G; Adejoorin I; Greisen SR; Chen L; Tirpack AK; Aude C; Fein MR; Todd DJ; MacFarlane L; Goodman SM; DiCarlo EF; Massarotti EM; Sparks JA; Jonsson AH; Brenner MB; Postow MA; Chan KK; Bass AR; Donlin LT; Rao DA
Sci Immunol; 2023 Jul; 8(85):eadd1591. PubMed ID: 37506196
[TBL] [Abstract][Full Text] [Related]
25. Possible pathogenetic relevance of interleukin-1 beta in "destructive" organ-specific autoimmune disease (Hashimoto's thyroiditis).
Paolieri F; Salmaso C; Battifora M; Montagna P; Pesce G; Bagnasco M; Richiusa P; Galluzzo A; Giordano C
Ann N Y Acad Sci; 1999 Jun; 876():221-8. PubMed ID: 10415613
[TBL] [Abstract][Full Text] [Related]
26. Increased IL-21/IL-21R expression and its proinflammatory effects in autoimmune thyroid disease.
Guan LJ; Wang X; Meng S; Shi LF; Jiang WJ; Xiao L; Shi XH; Xu J; Zhang JA
Cytokine; 2015 Apr; 72(2):160-5. PubMed ID: 25647271
[TBL] [Abstract][Full Text] [Related]
27. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis.
Han LT; Hu JQ; Ma B; Wen D; Zhang TT; Lu ZW; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
Diagn Pathol; 2019 Jun; 14(1):52. PubMed ID: 31159823
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of spontaneous resolution versus fibrosis in granulomatous experimental autoimmune thyroiditis.
Chen K; Wei Y; Sharp GC; Braley-Mullen H
J Immunol; 2003 Dec; 171(11):6236-43. PubMed ID: 14634140
[TBL] [Abstract][Full Text] [Related]
29. In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis.
Matsubayashi S; Akasu F; Kasuga Y; Snow K; Keystone E; Volpé R
Clin Exp Immunol; 1990 Oct; 82(1):63-8. PubMed ID: 1976464
[TBL] [Abstract][Full Text] [Related]
30. Human limbal fibroblast-like stem cells induce immune-tolerance in autoreactive T lymphocytes from female patients with Hashimoto's thyroiditis.
Coppola A; Tomasello L; Pitrone M; Cillino S; Richiusa P; Pizzolanti G; Giordano C
Stem Cell Res Ther; 2017 Jul; 8(1):154. PubMed ID: 28673339
[TBL] [Abstract][Full Text] [Related]
31. Lymphocytic Thyroiditis Transcriptomic Profiles Support the Role of Checkpoint Pathways and B Cells in Pathogenesis.
Álvarez-Sierra D; Marín-Sánchez A; Gómez-Brey A; Bello I; Caubet E; Moreno-Llorente P; Petit A; Zafón C; Iglesias C; González Ó; Pujol-Borrell R
Thyroid; 2022 Jun; 32(6):682-693. PubMed ID: 35403441
[No Abstract] [Full Text] [Related]
32. CD4
Yasuda Y; Iwama S; Sugiyama D; Okuji T; Kobayashi T; Ito M; Okada N; Enomoto A; Ito S; Yan Y; Sugiyama M; Onoue T; Tsunekawa T; Ito Y; Takagi H; Hagiwara D; Goto M; Suga H; Banno R; Takahashi M; Nishikawa H; Arima H
Sci Transl Med; 2021 May; 13(593):. PubMed ID: 33980577
[TBL] [Abstract][Full Text] [Related]
33. Detection and localization of chemokine gene expression in autoimmune thyroid disease.
Kemp EH; Metcalfe RA; Smith KA; Woodroofe MN; Watson PF; Weetman AP
Clin Endocrinol (Oxf); 2003 Aug; 59(2):207-13. PubMed ID: 12864798
[TBL] [Abstract][Full Text] [Related]
34. Evidence of a combined cytotoxic thyroglobulin and thyroperoxidase epitope-specific cellular immunity in Hashimoto's thyroiditis.
Ehlers M; Thiel A; Bernecker C; Porwol D; Papewalis C; Willenberg HS; Schinner S; Hautzel H; Scherbaum WA; Schott M
J Clin Endocrinol Metab; 2012 Apr; 97(4):1347-54. PubMed ID: 22259066
[TBL] [Abstract][Full Text] [Related]
35. Intrathyroidal and circulating lymphocyte subsets in different stages of autoimmune postpartum thyroiditis.
Jansson R; Tötterman TH; Sällström J; Dahlberg PA
J Clin Endocrinol Metab; 1984 May; 58(5):942-6. PubMed ID: 6608529
[TBL] [Abstract][Full Text] [Related]
36. A Global Regulatory Network for Dysregulated Gene Expression and Abnormal Metabolic Signaling in Immune Cells in the Microenvironment of Graves' Disease and Hashimoto's Thyroiditis.
Zheng H; Xu J; Chu Y; Jiang W; Yao W; Mo S; Song X; Zhou J
Front Immunol; 2022; 13():879824. PubMed ID: 35720300
[TBL] [Abstract][Full Text] [Related]
37. Tissue Infiltrating LTi-Like Group 3 Innate Lymphoid Cells and T Follicular Helper Cells in Graves' and Hashimoto's Thyroiditis.
Mohr A; Trésallet C; Monot N; Bauvois A; Abiven D; Atif M; Claër L; Malhotra R; Mayer G; Balderas R; Vaarala O; Deniziaut G; Brocheriou I; Buffet C; Leenhardt L; Gorochov G; Miyara M
Front Immunol; 2020; 11():601. PubMed ID: 32328068
[No Abstract] [Full Text] [Related]
38. Pre-existing Thyroiditis Ameliorates Papillary Thyroid Cancer: Insights From a New Mouse Model.
Pani F; Yasuda Y; Di Dalmazi G; Chalan P; Gabrielson K; Adamo L; Sabini E; Mariotti S; Caturegli P
Endocrinology; 2021 Oct; 162(10):. PubMed ID: 34331442
[TBL] [Abstract][Full Text] [Related]
39. Interactions of lymphocytes, thyrocytes and fibroblasts in Hashimoto's thyroiditis: an immunohistochemical and ultrastructural study.
Ben-Skowronek I; Szewczyk L; Ciechanek R; Korobowicz E
Horm Res Paediatr; 2011; 76(5):335-42. PubMed ID: 22024984
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of IL-17A Protects against Thyroid Immune-Related Adverse Events while Preserving Checkpoint Inhibitor Antitumor Efficacy.
Lechner MG; Cheng MI; Patel AY; Hoang AT; Yakobian N; Astourian M; Pioso MS; Rodriguez ED; McCarthy EC; Hugo W; Angell TE; Drakaki A; Ribas A; Su MA
J Immunol; 2022 Aug; 209(4):696-709. PubMed ID: 35817515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
